Estimation of ABCB1 concentration in plasma membrane

Area of Science:

• Cell Biology
• Biochemistry
• Pharmacology

Background:

• ABCB1 transporter interactions with substrates occur in cell membranes, but quantitative analysis is limited.
• Current methods express transporter amount per cell, not membrane concentration, hindering precise interaction studies.

Purpose of the Study:

• To develop and validate an approach for estimating the concentration of ABCB1 transporter molecules within plasma membranes.
• To quantify ABCB1 plasma membrane concentrations in human leukemia K562 cells with varying expression levels.

Main Methods:

• Utilized human leukemia K562 cell lines with differential ABCB1 expression, including drug-selected and RNA interference-modified lines.
• Determined absolute ABCB1 amounts in cell lysates via immunoblotting with a recombinant standard.
• Quantified the relative proportion of plasma membrane-resident ABCB1 using immunohistochemistry on non-permeabilized and permeabilized cells.

Main Results:

• Successfully estimated ABCB1 concentrations in the plasma membrane of resistant K562 cells.
• Drug-selected K562/Dox and K562/HHT cells exhibited high ABCB1 plasma membrane concentrations, reaching millimolar levels.
• Progressively decreased ABCB1 expression in K562/DoxDR2, K562/DoxDR1, and K562/DoxDR05 cells corresponded to proportionally reduced plasma membrane concentrations.

Conclusions:

• The developed approach enables accurate estimation of ABCB1 transporter concentration within the plasma membrane.
• High ABCB1 expression in drug-resistant leukemia cells leads to significant millimolar concentrations of the transporter in the plasma membrane.
• This quantitative data provides a foundation for better understanding transporter-substrate interactions and drug resistance mechanisms.